Company / Operating Income
ADC Therapeutics SA Operating Income History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$121.5M
FY2025
5-year range
-$166.0M / -$121.5M
FY2023-FY2025
Trend
+26.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$121M in FY2025.
Remained stable around -$121M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 26.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$121.5M | +26.8% |
| FY2024 | -$166.0M | -34.6% |
| FY2023 | -$123.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026